Filter
846
Text search:
assays
Featured
Recommendations
124
New Publications
204
Language
Document type
No document type
448
Guidelines
208
Studies & Reports
92
Manuals
38
Fact sheets
28
Strategic & Response Plan
21
Training Material
5
Situation Updates
3
Resource Platforms
2
Online Courses
1
Countries / Regions
India
47
Western and Central Europe
29
Global
28
Germany
17
Eastern Europe
16
Latin America and the Carribbean
15
Africa
15
South Africa
14
Kenya
13
Russia
12
Uganda
11
Tanzania
11
Sierra Leone
10
Nigeria
10
Brazil
10
East and Southern Africa
10
West and Central Africa
10
Liberia
9
Ukraine
9
Ethiopia
8
Malawi
8
Mozambique
8
Middle East and North Africa
8
Bangladesh
7
Namibia
6
Colombia
6
Nepal
5
Zambia
5
Cambodia
5
Angola
5
USA
4
Syria
4
Argentina
4
Peru
4
South–East Asia Region
4
Venezuela
4
Burkina Faso
3
Senegal
3
Congo, Democratic Republic of
3
Cameroon
3
Philippines
3
Rwanda
3
Sudan
3
Lesotho
3
Myanmar / Burma
3
Chile
3
Yemen
3
Asia
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Ghana
2
Niger
2
Zimbabwe
2
Somalia
2
Pakistan
2
Iraq
2
Jordan
2
Afghanistan
2
Lebanon
2
Egypt
2
Chad
2
Indonesia
2
Ecuador
2
El Salvador
2
Bolivia
2
Libya
2
Madagascar
2
Eastern Europe and Central Asia
2
Qatar
2
Guinea
1
Guinea-Bissau
1
Morocco
1
Haiti
1
Turkey
1
China
1
Mauritania
1
Benin
1
Dominican Republic
1
Eswatini/ Swaziland
1
Switzerland
1
Cuba
1
Honduras
1
Guatemala
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Western Pacific Region
1
Bhutan
1
Palestine
1
Djibouti
1
Mongolia
1
Congo-Brazzaville
1
Tajikistan
1
Estonia
1
Romania
1
Moldova
1
Iran
1
Kazakhstan
1
Georgia
1
North America
1
Jamaica
1
France
1
Tunisia
1
Portugal
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
234
Clinical Guidelines
150
Pharmacy & Technologies
48
Public Health
37
Women & Child Health
13
Key Resources
11
Capacity Building
2
Toolboxes
TB
169
COVID-19
122
HIV
108
Rapid Response
56
NTDs
49
Ebola
23
Zika
23
AMR
23
Pharmacy
15
Refugee
14
Polio
10
NCDs
10
Planetary Health
9
Conflict
5
Specific Hazards
5
Mental Health
3
Caregiver
3
Natural Hazards
2
Global Health Education
2
Cholera
1
Health Financing Toolbox
1
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Assurer des prestations optimales dans la chaîne de soins destinés aux patients tuberculeux
Deuxième édition - Juin 2018
Zoonotic tuberculosis (TB) is a form of TB in people predominantly caused by the bacterial species, Mycobacterium bovis, which belongs to the M. tuberculosis complex. The implications of zoonotic TB go beyond human health. The organism is host-adapted to cattle, where it is refer
...
Whole-genome sequencing (WGS) provides a vast amount of information and the highest possible resolution for pathogen subtyping. The application of WGS for global surveillance can provide information on the early emergence and spread of AMR and further inform timely policy development on AMR control.
...
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i
...
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Рекомендации, представленные в документе, в значительной степени
базируются на материалах по диагностике, профилактике и лечению COVID19, опубликованных специалист
...
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis
...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it
...
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the
...
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi
...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report
...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien
...
